NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1871554139 M.D.
Verify on CMS → Kelly Davis, M.D.
Endocrinology, Diabetes & Metabolism Physician in Wagoner, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 572 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
89%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Kelly Davis, M.D. filed 3,841 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Wagoner, Oklahoma, prescribing 89% generic.
- 4K
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥91st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kelly Davis, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1871554139), first enumerated 03/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,841 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1871554139 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1871554139
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 3,841
- BOOK-THIN 61 in Oklahoma
- PHOTO-ENUM Edward Brown · 2006
Kelly Davis, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
3,841 ≥ 91st percentile 91% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Kelly Davis, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kelly Davis, M.D.?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
3,841 46% vs specialty avg
Specialty distribution in Oklahoma
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Oklahoma providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1871554139 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/28/2006 |
Hospital and facility affiliations
Facilities where Kelly Davis, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Indian Health Care Resource Center
Tulsa, OK
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Kelly Davis, M.D. - brand share 10.0%
Endocrinology, Diabetes & Metabolism Physician average
10% brand-name claims vs 89% generic, on 3,841 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,841
Total Claims
$380K
Total Drug Cost
572
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,197
- Total Day Supply
- 240,931
- Brand vs Generic
- 10% brand / 89% generic
- Brand Drug Cost
- $293K
- Generic Drug Cost
- $84K
- Antibiotic Claims
- 46
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 96, 65-74: 289, 75-84: 144, 85+: 43
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Kelly Davis, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Rosuvastatin Calcium
Rosuvastatin Calcium
358 claims
- Losartan Potassium
Losartan Potassium
222 claims
- Metformin Hcl
Metformin Hcl
205 claims
- Lisinopril
Lisinopril
165 claims
- Celecoxib 127
Celecoxib
127 claims
- Nifedipine Er 112
Nifedipine Er
112 claims
- Atorvastatin Calcium 95
Atorvastatin Calcium
95 claims
- Glipizide 87
Glipizide
87 claims
| Drug | Claims |
|---|---|
| Rosuvastatin Calcium | 358 |
| Losartan Potassium | 222 |
| Metformin Hcl | 205 |
| Lisinopril | 165 |
| Celecoxib | 127 |
| Nifedipine Er Nifedipine | 112 |
| Atorvastatin Calcium | 95 |
| Glipizide | 87 |
| Diclofenac Sodium | 82 |
| Metoprolol Succinate | 81 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in OK →
All providers in Oklahoma →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Kelly Davis, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Kelly Davis, M.D.'s 3,841 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Davis, both outside Oklahoma so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Davis.
One of 61 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Oklahoma, 5 are shown here.
Dr. Elie Abed
M.D.
Tulsa, OK
Dr. Vaqar Ahmad
MD
Midwest City, OK
Dr. Hamsa Aljumaili
MD
Oklahoma City, OK
Dr. Bassam Arodak
MD
Oklahoma City, OK
Dr. Donald Aspenson
M.D.
Tulsa, OK
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kelly Davis, M.D.'s specialty? ▼
Kelly Davis, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Wagoner, Oklahoma. Credentials: M.D..
How much does Kelly Davis, M.D. prescribe under Medicare Part D? ▼
In 2023, Kelly Davis, M.D. wrote 3,841 Medicare Part D claims totaling $380K in drug costs for 572 beneficiaries.
Where is Kelly Davis, M.D. located? ▼
Kelly Davis, M.D. is located at 1202 W CHEROKEE ST STE H, Wagoner, OK, 74467. Phone: (918) 614-5533.
What is Kelly Davis, M.D.'s NPI number? ▼
Kelly Davis, M.D.'s National Provider Identifier (NPI) is 1871554139, issued on 03/28/2006.
Does Kelly Davis, M.D. prescribe more brand-name or generic drugs? ▼
Kelly Davis, M.D.'s prescribing is 10% brand-name and 89% generic drugs by claim count, with $293K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Kelly Davis, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Kelly Davis, M.D.'s most frequently prescribed drugs include Rosuvastatin Calcium, Losartan Potassium, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kelly Davis, M.D. accept Medicare? ▼
Kelly Davis, M.D. appears in CMS Medicare data with 3,841 Part D claims and 572 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kelly Davis, M.D.'s credentials? ▼
Kelly Davis, M.D.'s NPI is 1871554139 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.